Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 1

Ethnicity-matched case–control study reveals significant gut microbiota differences in Malaysian adults with type 2 diabetes No Access

Abstract

Type 2 diabetes mellitus (T2DM) is a major global health issue projected to exceed 700 million cases by 2045. In Malaysia, T2DM prevalence has risen, with notable ethnic disparities.

The gut microbiota’s role in T2DM pathogenesis is well recognized, yet its composition in Malaysia’s ethnically diverse population remains underexplored.

This study aimed to characterize gut microbiota composition among T2DM and ethnicity-matched adults without diabetes (nonDM) in Malaysia.

A case–control study was conducted with 45 T2DM and 45 nonDM participants matched by ethnicity from a primary care clinic in Klang Valley, Malaysia. Faecal DNA was subjected to 16S rRNA sequencing to identify microbiota diversity and composition differences and compare predicted functional capabilities. Correlations between bacterial taxa, clinical characteristics and dietary intake were analysed.

T2DM participants showed decreased alpha diversity (observed, -value=0.002, =0.69; Shannon, -value<0.001, =0.73) and significant differences in beta diversity (permutational multivariate ANOVA, ²=0.036, -value=0.001). Linear discriminant analysis effect size and multiple regression analysis, adjusted for covariates age, gender, BMI and intakes of protein, fat, carbohydrate and fibre, identified the phylum and genera to be increased, while the genera and decreased in T2DM. These bacteria were associated with various clinical characteristics and dietary intake. However, these ‘potential biomarkers’ were not uniformly present across all participants, suggesting that individual bacterial taxa may not serve as universal biomarkers.

Significant gut microbiota differences exist between T2DM and nonDM individuals in Malaysia, indicating a dysbiosis characterized by increased pro-inflammatory bacteria and reduced short-chain fatty acid-producing bacteria in T2DM. While these findings highlight the potential functional relevance of gut microbiota in T2DM pathogenesis, addressing limitations such as participant matching for confounding factors in future studies could uncover additional significant differences in microbiota composition. Furthermore, the variability in taxa prevalence across individuals suggests that targeting microbial metabolic products may offer more promising strategies to inform microbiota-targeted interventions than relying solely on specific bacterial taxa as biomarkers.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): dietary intake , ethnicity-matched control study , gut microbiota , Malaysia , microbiome and type 2 diabetes
Funding
This study was supported by the:
  • Kementerian Pendidikan Malaysia (Award FRGS/1/2018/SKK08/USIM/02/1)
    • Principal Award Recipient: Gowri PathmanathanSiva
© 2025 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001963
2025-01-31
2025-12-10

Metrics

Loading full text...

Full text loading...

References

  1. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62:3–16 [View Article]
     [Google Scholar]
  2. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183:109119 [View Article] [PubMed]
     [Google Scholar]
  3. Institute for Public Health (IPH). National Health and Morbidity Survey (NHMS) Non-communicable Diseases and Healthcare Demand - Key Findings 2024; 2023 www.iku.gov.my/nhms
  4. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498:99–103 [View Article] [PubMed]
     [Google Scholar]
  5. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5:e9085 [View Article] [PubMed]
     [Google Scholar]
  6. Qin J, Li Y, Cai Z, Li S, Zhu J et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490:55–60 [View Article] [PubMed]
     [Google Scholar]
  7. Letchumanan G, Abdullah N, Marlini M, Baharom N, Lawley B et al. Gut microbiota composition in prediabetes and newly diagnosed type 2 diabetes: a systematic review of observational studies. Front Cell Infect Microbiol 2022; 12:943427 [View Article] [PubMed]
     [Google Scholar]
  8. Neoh H, Osman MA, Ab Mutalib NS, Chin SF, Ang MY. Gut microbiome profiling of malaysians: a snapshot. IDDF 20189–10 [View Article]
     [Google Scholar]
  9. Dwiyanto J, Hussain MH, Reidpath D, Ong KS, Qasim A et al. Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country. Sci Rep 2021; 11:2618 [View Article] [PubMed]
     [Google Scholar]
  10. Department of statistics Malaysia. Third quarter [2024] Demography n.d https://open.dosm.gov.my/publications/demography_2024-q3
     [Google Scholar]
  11. Clinical Practice Guidelines (CPG) Management Of Type 2 Diabetes Mellitus (6th Edition); 2020 http://mems.my/
  12. World Health Organization (WHO) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation; 2006
  13. Institute for Public Health (IPH) National health and morbidity survey 2014: Malaysian adult nutrition survey (MANS) vol II: survey findings 2014 p 343
     [Google Scholar]
  14. Tee ES, Nasir MA, Katijah I. Nutrient composition of malaysian foods, 4th ed Kuala Lumpur: Malaysian food composition database programme. Institute for Medical Research; 1997
  15. MyFCD Malaysian food composition database (myfcd): institute for medical research. Kuala Lumpur; 1997 https://myfcd.moh.gov.my/index.html
  16. Illumina 16s metagenomics library preparation guideline 2013. n.d https://support.illumina.com/documents/documentation/chemistry_documentation/16s/16s-metagenomic-library-prep-guide-15044223-b.pdf
  17. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019; 37:852–857 [View Article]
     [Google Scholar]
  18. Lu Y, Zhou G, Ewald J, Pang Z, Shiri T et al. MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res 2023; 51:W310–W318 [View Article] [PubMed]
     [Google Scholar]
  19. Dhariwal A, Chong J, Habib S, King IL, Agellon LB et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res 2017; 45:W180–W188 [View Article] [PubMed]
     [Google Scholar]
  20. Callahan BJ. DADA2 Pipeline Tutorial (1.16); 2020 https://benjjneb.github.io/dada2/tutorial.html
  21. Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 2016; 32:3047–3048 [View Article] [PubMed]
     [Google Scholar]
  22. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 2013; 41:D590–6 [View Article] [PubMed]
     [Google Scholar]
  23. Robeson MS 2nd, O’Rourke DR, Kaehler BD, Ziemski M, Dillon MR et al. RESCRIPt: reproducible sequence taxonomy reference database management. PLoS Comput Biol 2021; 17:e1009581 [View Article] [PubMed]
     [Google Scholar]
  24. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statist 2001; 29:1165–1188 [View Article]
     [Google Scholar]
  25. Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 2014; 30:3123–3124 [View Article] [PubMed]
     [Google Scholar]
  26. Houtman TA, Eckermann HA, Smidt H, de Weerth C. Gut microbiota and BMI throughout childhood: the role of firmicutes, bacteroidetes, and short-chain fatty acid producers. Sci Rep 2022; 12:3140 [View Article] [PubMed]
     [Google Scholar]
  27. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021; 19:55–71 [View Article] [PubMed]
     [Google Scholar]
  28. Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S et al. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?. Nutrients 2020; 12:1–17 [View Article] [PubMed]
     [Google Scholar]
  29. Doumatey AP, Adeyemo A, Zhou J, Lei L, Adebamowo SN et al. Gut microbiome profiles are associated with type 2 diabetes in urban Africans. Front Cell Infect Microbiol 2020; 10:63 [View Article] [PubMed]
     [Google Scholar]
  30. Navab-Moghadam F, Sedighi M, Khamseh ME, Alaei-Shahmiri F, Talebi M et al. The association of type II diabetes with gut microbiota composition. Microb Pathog 2017; 110:630–636 [View Article] [PubMed]
     [Google Scholar]
  31. Chen Z, Radjabzadeh D, Chen L, Kurilshikov A, Kavousi M et al. Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies. JAMA Netw Open 2021; 4:e2118811 [View Article] [PubMed]
     [Google Scholar]
  32. Therdtatha P, Song Y, Tanaka M, Mariyatun M, Almunifah M et al. Gut microbiome of Indonesian adults associated with obesity and type 2 diabetes: a cross-sectional study in an Asian city, Yogyakarta. Microorganisms 2021; 9:897 [View Article] [PubMed]
     [Google Scholar]
  33. Zeng Q, Li D, He Y, Li Y, Yang Z et al. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Sci Rep 2019; 9:13424 [View Article]
     [Google Scholar]
  34. Diener C, Reyes-Escogido M de L, Jimenez-Ceja LM, Matus M, Gomez-Navarro CM et al. Progressive shifts in the gut microbiome reflect prediabetes and diabetes development in a treatment-naive Mexican cohort. Front Endocrinol 2021; 11:1–13 [View Article]
     [Google Scholar]
  35. Zeevi D, Korem T, Godneva A, Bar N, Kurilshikov A et al. Structural variation in the gut microbiome associates with host health. Nature 2019; 568:43–48 [View Article] [PubMed]
     [Google Scholar]
  36. Singh V, Lee G, Son H, Koh H, Kim ES et al. Butyrate producers, “the sentinel of gut”: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol 2022; 13:1103836 [View Article] [PubMed]
     [Google Scholar]
  37. Mayorga-Ramos A, Barba-Ostria C, Simancas-Racines D, Guamán LP. Protective role of butyrate in obesity and diabetes: new insights. Front Nutr 2022; 9:1067647 [View Article] [PubMed]
     [Google Scholar]
  38. Everard A, Cani PD. Gut microbiota and GLP-1. Rev Endocr Metab Disord 2014; 15:189–196 [View Article] [PubMed]
     [Google Scholar]
  39. Cui J, Ramesh G, Wu M, Jensen ET, Crago O et al. Butyrate-producing bacteria and insulin homeostasis: the Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes 2022; 71:2438–2446 [View Article] [PubMed]
     [Google Scholar]
  40. Zhao L, Zhang F, Ding X, Wu G, Lam YY et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 2018; 359:1151–1156 [View Article]
     [Google Scholar]
  41. Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 2013; 7:880–884 [View Article] [PubMed]
     [Google Scholar]
  42. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761–1772 [View Article] [PubMed]
     [Google Scholar]
  43. Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol 2020; 11:594150 [View Article] [PubMed]
     [Google Scholar]
  44. Anhê FF, Barra NG, Cavallari JF, Henriksbo BD, Schertzer JD. Metabolic endotoxemia is dictated by the type of lipopolysaccharide. Cell Rep 2021; 36:109691 [View Article] [PubMed]
     [Google Scholar]
  45. d’Hennezel E, Abubucker S, Murphy LO, Cullen TW. Total lipopolysaccharide from the human gut microbiome silences toll-like receptor signaling. mSystems 2017; 2:1–12 [View Article]
     [Google Scholar]
  46. Bryrup T, Thomsen CW, Kern T, Allin KH, Brandslund I et al. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. Diabetologia 2019; 62:1024–1035 [View Article] [PubMed]
     [Google Scholar]
  47. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015; 528:262–266 [View Article] [PubMed]
     [Google Scholar]
  48. Burrows TL, Ho YY, Rollo ME, Collins CE. Validity of dietary assessment methods when compared to the method of doubly labeled water: a systematic review in adults. Front Endocrinol 2019; 10:850 [View Article] [PubMed]
     [Google Scholar]
  49. Mirnalini JK, Zalilah M, Safiah M, Tahir A, Haslinda S et al. Energy and nutrient intakes: findings from the Malaysian Adult Nutrition Survey (MANS). Malays J Nutr 2008; 14:1–24
     [Google Scholar]
  50. Zainuddin AA, Md Nor N, Md Yusof S, Nur Ibrahim AI, Aris T et al. Under-reporting of energy and nutrient intake is a persistent issue in the malaysian adult nutrition surveys. Mal J Nutr 2019; 25:261–271 [View Article]
     [Google Scholar]
  51. Ravelli MN, Schoeller DA. Traditional self-reported dietary instruments are prone to inaccuracies and new approaches are needed. Front Nutr 2020; 7:90 [View Article]
     [Google Scholar]
  52. Bastos RM, Rangel ÉB. Gut microbiota-derived metabolites are novel targets for improving insulin resistance. WJD 2022; 13:65–69 [View Article]
     [Google Scholar]
  53. Zimmermann P, Curtis N. The effect of antibiotics on the composition of the intestinal microbiota - a systematic review. J Infect 2019; 79:471–489 [View Article] [PubMed]
     [Google Scholar]
  54. Tannock GW. Scoring microbiota function: a proposal to use features of evolutionary, symbiotic innovation to recognize a “healthy” human gut microbiota. Gut Microbes 2024; 1:1–7 [View Article]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001963
Loading
Ethnicity-matched case–control study reveals significant gut microbiota differences in Malaysian adults with type 2 diabetes
J. Med. Microbiol. 74, 001963 (2025); https://doi.org/10.1099/jmm.0.001963
/content/journal/jmm/10.1099/jmm.0.001963
/content/journal/jmm/10.1099/jmm.0.001963
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error